Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07TYM
|
|||
| Former ID |
DIB009255
|
|||
| Drug Name |
Autologous T-lymphocyte cell therapy
|
|||
| Synonyms |
Autologous T-lymphocyte cell therapy (G250-scFV-transduced, renal cell carcinoma)
Click to Show/Hide
|
|||
| Indication | Peripheral vascular disease [ICD-11: BD4Z; ICD-10: I73, I73.9] | Phase 2 | [1] | |
| Company |
Pervasis Therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlook. Cancer J. 2012 Mar-Apr;18(2):160-75. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.